Welcome toBrown Retina Institute
Dr. Brown participates in the National Quality of Care Initiative for the Medicare PQRS program.
Click here for more information.
We are committed to providing the best retina care . We do this by providing state-of-the-art retina diagnosis and treatment in a compassionate, caring environment. Our patient centered approach is practiced by everyone in the office. We will always strive to treat you with highest respect and fairness. In addition to treating your condition, we will take the time to explain your diagnosis, treatment plan and future course.
Located in San Antonio, Texas, Dr. Jeremiah Brown is a nationally recognized retina specialist, graduate of Harvard University, author, researcher and father. He is a bilingual, board certified ophthalmologist who has been awarded the American Academy of Ophthalmology Achievement Award. Dr. Brown served with distinction as a vitreoretinal surgeon in the US Army and was awarded the Army Meritorious Service Award. Dr. Brown specializes in many areas, including:
We look forward to having the opportunity to meet with you, discuss your condition and work with you in planning your care.
Call to schedule an appointment today.
Dr. Brown Speaks Spanish
On April 15, 2017, Dr. Brown will lecture to the Macular Degeneration Association in Clearwater Florida. The lecture will discuss Diabetes and its effects on the Eyes as well as the Latest News in Macular Degeneration. The lecture will be held at 8:30 am at Ruth Eckerd Hall, 1111 McMullen Booth Rd., Clearwater Florida 33759.
On April 22, 2017, Dr. Brown will lecture to the Macular Degeneration Association in The Villages Florida. The lecture will discuss Diabetes and its effects on the Eyes as well as the Latest News in Macular Degeneration. The lecture will be held at 8:30 am at The Waterfront Inn, 1105 Lakeshore Drive, The Villages, Florida 32162.
In a recent study of 660 patients with diabetic macular edema, Lucentis, Eylea and Avastin were found to equally effective, on average, in treating this complication of diabetes. Some patients with vision poorer than 20/50 may achieve greater visual acuity benefit with Eylea.
Treatment for wet Age Related Macular Degeneration with anti-VEGF medications reduced the likelihood of being admitted to a nursing home. These findings reported by researchers at Duke University, demonstrates that by delaying vision loss, treated patients were more likely to remain independent than untreated
… read more.